RAAS inhibitors | Docwire News

RAAS inhibitors

Charlotte RobinsonWCN 2025 | February 10, 2025

Can SZC help with RAASi maximization without resultant hyperkalemia in patients with HFrEF and CKD?

Ajay K. Singh, MBBS, FRCP, MBAChronic Kidney Disease | February 5, 2024

From the Chair ...

Victoria SochaNational Kidney Foundation 2022 | February 5, 2024

Treatment with renin-angiotensin-aldosterone system inhibitors (RAASi) provides cardiorenal protection. However, due to ...

Victoria SochaChronic Kidney Disease | February 5, 2024

Patients treated with renin-angiotensin-aldosterone system inhibitors (RAASis) commonly experience hyperkalemia. ...

DocWire News EditorsASN Kidney Week 2021 | February 5, 2024

Researchers have hypothesized that direct viral invasion of the kidney via angiotensin converting enzyme is a mechanism ...

Victoria SochaHyperkalemia | June 30, 2023

In a recent issue of Clinical Epidemiology, Santiago-Jiménez-Marrero and colleagues reported results of an analysis ...

DocWire News EditorsCardiology | July 7, 2023

Concentrations of a particular enzyme that acts as a receptor for coronaviruses (including SARS-CoV-2) are higher in men ...

Victoria SochaChronic Kidney Disease | June 30, 2023

Blocking the renin-angiotensin-aldosteronesystem with ACE inhibitors or ARBs is beneficial in reducing cardiovascular risk.